Monte Rosa Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $167k | 24k | 6.94 |
| 2024-09-30 | $98k | 19k | 5.30 |
| 2024-06-30 | $50k | 13k | 3.74 |
| 2024-03-31 | $90k | 13k | 7.05 |
| 2023-12-31 | $124k | 22k | 5.65 |
| 2023-09-30 | $141k | 30k | 4.79 |
| 2023-06-30 | $174k | 25k | 6.85 |
| 2023-03-31 | $13k | 1.6k | 7.93 |
| 2022-12-31 | $140k | 18k | 7.63 |
| 2022-06-30 | $171k | 18k | 9.65 |
| 2022-03-31 | $319k | 23k | 14.16 |
| 2021-12-31 | $240k | 12k | 20.53 |